SFU Library Licensed Material

Access to the content in this collection is restricted to current SFU faculty, students, and staff.

This collection contains various types of content licensed by the SFU Library on behalf of the University. 

Copyright and Terms of use

This work is protected by copyright in Canada unless its copyright has expired. The user is responsible for doing their own assessment. 

You may use this work as permitted by applicable licenses, fair dealing and other exceptions under copyright legislation in your jurisdiction. For guidance on seeking further permissions, contact the source/owner of the material.

Search within Collection

Displaying 91 - 105 of 710

Drug Discovery Collaborations between Academia and the Pharmaceutical Industry,Datamonitor report

BI00020-034-Thumbnail Image.png
Date: 2010-07-06
Name(s): Taylor, Paul
Description: The pharmaceutical industry has sought collaborations with academia to obtain access to new technologies and to in-license candidates for further development with the overall aim of reinvigorating drug discovery pipelines.

Drug Repositioning Strategies,Datamonitor report

BI00020-005-Thumbnail Image.png
Date: 2007-06-01
Name(s): Barton, Cheryl L.
Description: Drug repositioning is regarded as the pharma industry's solution to falling R&D productivity and weakened product pipelines. Successful repositioned drugs have enabled innovative companies to adopt lower risk strategies to optimize their pipelines.

Drug Safety in the Post-Vioxx Era,Datamonitor report

BI00027-046-Thumbnail Image.png
Date: 2005-07-14
Name(s): Sahoo, Alison
Description: Although Vioxx is the most severe safety scare to date, similar problems could occur again given the commercial availability of various products that have been linked to widespread severe reactions and the lack of sufficient regulatory controls.

Early Stage Drug Safety Strategies and Risk Management,Datamonitor report

BI00020-019-Thumbnail Image.png
Date: 2009-04-27
Name(s): Barton, Cheryl L.
Description: Declining productivity has forced companies to urgently address the areas of drug development that are most likely to lead to attrition. Innovations are required that can support the earlier termination of drugs which will be toxic to humans.

Effective Utility Company Customer Acquisition and Retention Strategies,Datamonitor report

BI00038-003-Thumbnail Image.png
Date: 2011-03-23
Description: A vital factor driving electricity switching trends is the electricity price, which acts as a major driver for a customer willing to switch to another retail electricity supplier.

Effective Vendor Strategies for Targeting SMBs,Datamonitor report

BI00029-028-Thumbnail Image.png
Date: 2009-06-08
Name(s): Furness, Victoria
Description: SMBs represent an important and growing market for many IT product and services vendors. Although their individual budgets are smaller than those controlled by larger enterprises, SMBs still understand that IT is critical to their business.

eHealth Solutions for Pharma,Datamonitor report

BI00027-003-Thumbnail Image.png
Date: 2007-03-16
Description: The online channel offers a key opportunity for pharma companies to restructure their sales and marketing model, improving their relationships with physicians and increasing compliance among patients.

Emballages pour matières infectieuses de catégorie A et de catégorie B (classe 6.2) et déchet d'hôpital, (bio) médical ou médical réglementé

sfulibr_1222-Thumbnail Image.png
Date: 2016-04-27

Emerging Clinical Trial Locations -China,Datamonitor report

BI00025-011-Thumbnail Image.png
Date: 2009-06-17
Name(s): Taylor, Paul
Description: Emerging markets offer significant advantages to the traditional clinical trial settings i.e. rapid recruitment of treatment naive patients from large patient pool, cost benefits associated with lower labor and service fees.

Emerging Clinical Trial Locations -India,Datamonitor report

BI00025-013-Thumbnail Image.png
Date: 2009-06-17
Name(s): Taylor, Paul
Description: Emerging markets offer significant advantages to the traditional clinical trial settings i.e. rapid recruitment of treatment naive patients from large patient pool, cost benefits associated with lower labor and service fees.

Emerging Clinical Trial Locations -Latin America,Datamonitor report

BI00025-012-Thumbnail Image.png
Date: 2009-06-17
Name(s): Taylor, Paul
Description: Emerging markets offer significant advantages to the traditional clinical trial settings i.e. rapid recruitment of treatment naive patients from large patient pool, cost benefits associated with lower labor and service fees.

Emerging Clinical Trial Locations Eastern Europe,Datamonitor report

BI00025-010-Thumbnail Image.png
Date: 2009-06-17
Name(s): Taylor, Paul
Description: Emerging markets offer significant advantages to the traditional clinical trial settings i.e. rapid recruitment of treatment naive patients from large patient pool, cost benefits associated with lower labor and service fees.

Emerging Clinical Trial Locations,Datamonitor report

BI00025-014-Thumbnail Image.png
Date: 2009-06-22
Name(s): Taylor, Paul
Description: Emerging markets offer significant advantages to the traditional clinical trial settings i.e. rapid recruitment of treatment naive patients from large patient pool, cost benefits associated with lower labor and service fees.

Emerging Consumer Electronics Markets,Datamonitor report

BI00028-023-Thumbnail Image.png
Date: 2010-11-29
Description: Emerging markets in Asia-Pacific, Middle East and Africa, Eastern Europe and Latin America are offering significant growth opportunities for consumer electronics manufacturers, who are currently facing stagnating sales in mature markets.

Emerging Enterprise Applications Vendors,Datamonitor report

BI00029-027-Thumbnail Image.png
Date: 2009-05-02
Description: The enterprise applications market is undergoing a radical shift from on-premise to on-demand (Internet/cloud computing) structure. This shift is similar to the one in 1980s that witnessed move from the mainframe to the client/server model.